Sleep Apnea, Obstructive Withdrawn Phase Trials for Acetazolamide (DB00819)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00108602Sleep Apnea: Mechanism and Cerebrovascular ConsequencesDiagnostic